Sigachi Laboratories Limited Unlisted Shares|Latest Share Price & Updates
Sigachi Laboratories Limited is a public company incorporated on 21st November 1994. It is classified as a non-government company and is registered at Registrar of Companies, Hyderabad. Sigachi Laboratories Limited operates as a pharmaceutical company. The company focuses on the business of manufacturing bulk drugs and drug intermediates and also carries on investments in shares and securities. In FY21, the company generated most of its revenue from investments.
The Sigachi shares have been listed at Metropolitan stock exchange. Apart from manufacturing drugs, the company is also involved in investing, and mostly invests in equity and mutual funds with its primary focus on pharmaceuticals, banking, and energy sectors.
Sigachi Industries Limited is an unlisted public company incorporated on 11 January, 1989. It is classified as a public limited company and is located in Hyderabad, Telangana. Its authorized share capital is INR 32.00 crores and the total paid-up capital is INR 30.74 cr.
Sigachi Industries Limited’s operating revenues range is INR 100 crores – 500 crores for the financial year ending on 31 March, 2022. Its EBITDA has increased by 34.98 % over the previous year. At the same time, its book net-worth has increased by 139.40 %. Other performance and liquidity ratios are available here.
Description: The company manufactures micro crystalline cellulose (MCC), widely used in pharmaceutical, food, beverage, cosmetic and paint industries.
Products & Services: Pharma Industry, Chemical Industry, Cosmetic Industry, Food Industry.
The current status of Sigachi Industries Limited is – Active.
The last reported AGM (Annual General Meeting) of Sigachi Industries Limited, per our records, was held on 29 August, 2022. Also, as per our records, its last balance sheet was prepared for the period ending on 31 March, 2022.
|Symbol:||Sigachi Laboratries Ltd.|
|Face Value (₹):||10|
|Demat Status:||NSDL & CDSL|
Board of Directors:
|Ms. Shilpa Bung||Additional Director|
|Mr. Mohanrao Gurram||Director|
|Mr. Tadepalli Rao Govardhana||Director|
|Mr. Adinarayana Tunuguntla||Director|
|Mr. Rajasekhar Tunuguntla||Wholetime Director|
|Mr. Lakshmana Venkata Subba Rao Patchipulusu||Director|
- One of India’s largest manufacturers of Bulk Drugs and Drug Intermediates.
- The company operates high-tech manufacturing plants in Telangana.
- The company more than doubled its revenue and tripled its profitability during FY 2021
- The business has very high operating margins
- The company has a diversified client base across North-America, Europe, Middle East, Africa and Asia.
|Net Profit Margin||66%||71%|
|Return on Equity||7%||10%|
Note:- Dividend payout = Total Dividend/Net Income.
It indicates, how much % of its Net Income, the company is paying out as dividend to its Shareholders.
|Total Income (₹ Crores)||3.04||3.86||1.73||1.98||2.09|
|PAT (₹ Crores)||2.00||2.75||0.71||1.05||1.11|
|Book Value per Share (₹)||40.69||36.62||27.19||29.27||27.09|
|Equity (₹ Crores)||29.75||26.77||19.87||21.40||19.81|
|Company||Market Cap (₹ Crores)||Profitability Margin (%)||ROCE (%)||ROE (%)||D/E Ratio||P/E Ratio||P/B Ratio||Book Value per Share (₹)|
|Sigachi Laboratories Ltd||28||66%||8%||7%||0.00||12.84||0.93||40.69|
|IOL Chemicals and Pharmaceuticals Ltd||2408||8%||17%||12%||0.03||12.53||1.49||236.80|
|Divis Laboratories Ltd||94371||33%||30%||25%||0.00||39.47||9.97||441.82|
Frequently Asked Questions
The buying and selling of unlisted shares and pre-IPO shares is fully legal and valid.
The procedure to buy the Sigachi Laboratories unlisted shares is fairly simple. Once you have settled on the price and quantity of the transaction, you would have to transfer the funds into the bank account of the seller.
When the funds are transferred and transaction details are shared with the seller, your demat account will be credited with the shares either on the same day of the fund transfer or before the end of the next working day.
In the secondary market, the transactions related to unlisted shares take place with the existing owners of the shares who are generally the employees or existing investors in the company. The company itself is not directly involved.
The Sigachi Laboratories shares will get credited either the same day or before the end of the next working day when you transfer the funds into our bank account.
The minimum lot size varies on the basis of market conditions and demand and supply factors. To know the current lot size for Sigachi Laboratories Ltd unlisted shares, please visit the stock page on our website: www.delistedstocks.in
There are many factors which influence the pricing of unlisted shares. Apart from the supply and demand factors, the latest transactions happened on the same stock, last funding round of the company, and valuation level of companies of the similar size affect the pricing of the unlisted shares.
Before IPO, there is no restriction on sale and transfer of your Sigachi Laboratories unlisted shares.
But once the shares are listed on the stock exchange, for retail investors, there is a minimum lock-in period 6 months after listing on the stock exchange.
Once the selling price and quantity of shares is agreed with us, we will provide you with an UTR number to transfer the shares. Once you have transferred the shares into our company’s demat account, funds will be released into your bank account within 24 hours or before the end of the next working day of the transfer of the shares.
If your holding period is less than 2 years, then such income is treated as business income and liable to get taxed as per tax slab of the investor.
If your holding period is more than 2 years, then your profits would be subject to long-term capital gains tax. The current short-term capital gain tax rate is 20% after indexation.
The trading in unlisted shares is governed by Securities & Contract (Regulation) Act, which comes under the preview of SEBI. The SEBI regulations become applicable when the stocks of the company get listed on the stock exchange. There is a minimum lock-in period of 6 months for pre-IPO investors.
The major risk associated with investing in unlisted stocks is the liquidity risk. The possible exit route for investors is either to sell to another investor or wait till the company gets listed on the stock exchange.
Yes, NRI’s can also buy and sell Sigachi Laboratories unlisted shares just like domestic investors. But their investment is on a non-repatriable basis.